How Many People Can Squeeze Into A Mid-Cycle Meeting? For Savaysa, The Number Is 70
Executive Summary
NDA’s complexity and a major efficacy review issue on the a-fib indication help explain the large contingent of FDA and sponsor participants in meetings required under the PDUFA V review ‘Program.’